Algernon Pharmaceuticals study of Ifenprodil for Fibrosis and chronic cough reaches key stage
Algernon Pharmaceutical CEO Christopher Moreau joined Steve Darling from Proactive to share news the company has announced positive information showing the...
Source: proactiveinvestors.com